EUVIMEDEUVIMED entdecken
Open Access

Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia

Naga Chalasani iD, Ismael Alvarez-Alvarez iD, Paul H Hayashi iD, Raj Vuppalanchi iD, Marwan Ghabril, Ronald Kamusiime iD, Huiman Barnhart iD, Hao Niu iD, M Isabel Lucena iD, Raul J Andrade iD, Drug Induced Liver Injury Network

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Naga Chalasani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alanine Transaminase, Aspartate Aminotransferases, Chemical and Drug Induced Liver Injury, Hyperbilirubinemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated aminotransferases with concomitant jaundice in drug‐induced liver injury (DILI) are associated with adverse outcomes, but the prognostic significance of very high aminotransferases without jaundice is unclear. We examined selected outcomes of patients with DILI and markedly elevated aminotransferases but normal or near‐normal total bilirubin (TBL). We analyzed the data from the prospective Drug‐Induced Liver Injury Network (DILIN) and the Spanish DILI registries. Patients were categorized based on peak alanine or aspartate aminotransferase (ALT/AST) levels—very high (500–1,000 U/L) or towering (>1,000 U/L)—and concomitant normal (≤1.0 mg/dL) or near‐normal (1.1–2.5 mg/dL) TBL levels. Primary outcome was subsequent development of nR‐based Hy's Law (nR ≥5 with TBL >2.5 mg/dL). A total of 964 patients were analyzed (692 DILIN; 272 Spanish DILI). In both cohorts, very high aminotransferases with normal TBL were rarely followed by nR‐based Hy's Law. In DILIN, only 1.3% of patients with very high ALT and normal TBL developed nR‐based Hy's Law, whereas risk increased markedly with minimally elevated TBL (odds ratio (OR) 7.8). Towering aminotransferases conferred increased risk regardless of TBL, with the highest risk observed when accompanied by minimally elevated TBL (OR 23.6). Similar inflection points were observed in the Spanish DILI Registry, in patients with very high aminotransferases and minimally elevated TBL or towering aminotransferases with or without elevated TBL. In conclusion, patients with DILI and very high aminotransferases may tolerate liver injury well when bilirubin is normal, but even minimal bilirubin elevation or towering aminotransferases signal increased risk for poor outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alanine TransaminaseAspartate AminotransferasesChemical and Drug Induced Liver InjuryHyperbilirubinemiaHumansMaleFemaleBilirubinMiddle AgedRegistriesSpainProspective StudiesAgedBiomarkersPrognosisRisk FactorsJaundice

Substanzen

Alanine TransaminaseAspartate AminotransferasesBilirubinBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA) - Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Food and Drug Administration, Silver Spring, Maryland, USA.
  • Duke University, Durham, North Carolina, USA.

ORCID-Profile: Naga Chalasani, Ismael Alvarez-Alvarez, Paul H Hayashi, Raj Vuppalanchi, Ronald Kamusiime, Huiman Barnhart, Hao Niu, M Isabel Lucena, Raul J Andrade

Zitieren

APA

Chalasani, N., Alvarez-Alvarez, I., Hayashi, P. H., Vuppalanchi, R., Ghabril, M., Kamusiime, R., Barnhart, H., Niu, H., Lucena, M. I., Andrade, R. J., & Drug Induced Liver Injury Network (2026). Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70397

Vancouver

Chalasani N, Alvarez-Alvarez I, Hayashi PH, Vuppalanchi R, Ghabril M, Kamusiime R, et al. Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70397

BibTeX
@article{Chalasani2026,
  author = {Chalasani, Naga and Alvarez-Alvarez, Ismael and Hayashi, Paul H and Vuppalanchi, Raj and Ghabril, Marwan and Kamusiime, Ronald and Barnhart, Huiman and Niu, Hao and Lucena, M Isabel and Andrade, Raul J and Drug Induced Liver Injury Network, Drug Induced Liver Injury Network},
  title = {Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70397}
}
Kostenlos starten →